The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Permeability and Residual Plasma Volume of Human, Dutch Variant, and Rat Amyloid β-Protein 1-40 at the Blood–Brain Barrier
Abstract
The permeability of normal human, the human Dutch variant, and the rat A beta 1-40 proteins at the blood-brain barrier (BBB) was determined in the normal adult rat by quantifying the permeability coefficient-surface area (PS) product for each protein after correction for the residual plasma volume (Vp) occupied by the protein in the blood vessels of different brain regions. The PS for normal and Dutch A beta ranged from 13 x 10(-6) to 22 x 10(-6) ml/g/s in different brain regions, which is 130 to 220 times greater than albumin. These high PS values compare to that of insulin, whose uptake is decidedly by a receptor-mediated transport process, and suggest a similar mechanism for A beta. Remarkably, the PS for rat A beta was 4 times higher and ranged from 54 x 10(-6) to 82 x 10(-6) ml/g/s for different brain regions, suggesting a distinctive species specificity. While the Vp values of human and rat A beta were comparable, the Dutch variant was 2 to 3 times higher, indicating adherence to the vessel walls in different brain regions, consistent with the heavy A beta deposition that has been described in intracerebral vessel walls with this variant. The high PS values observed for A beta at the BBB suggest that sources outside the nervous system could contribute, at least in part, to the cerebral A beta deposits seen in Alzheimer's disease. SDS-PAGE of 125I-labeled human A beta after 60 min of uptake revealed intact protein in plasma and in different brain regions. In addition, 12…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous studies from our laboratory and others have demonstrated a major role of the BBB in determining the concentrations of A b in the CNS by regulating transport of circulating A b (33, 39, 49-51, 62-66).”
From Clearance of Alzheimer’s amyloid-β1-40 peptide from brain by LDL receptor–related protein-1 at the blood-brain barrier (2000) · cites this paper as [50]
Citations
Cites
Macromolecular permeability across the blood-nerve and blood-brain barriers.
Poduslo, J. F., Curran, G. L., & Berg, C. T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5705 · Cited by 377
Self-citation
Research works printed but not linked: 36
- Biere, 1996, Amyloid β-peptide (Aβ) is transported on lipoproteins and albumin in human plasma, J. Biol. Chem., 271, 32916, 10.1074/jbc.271.51.32916 · DOI · Paper page
- Clemens, 1992, Implants containing β-amyloid protein are not neurotoxic to young and old rat brain, Neurobiol. Aging, 13, 581, 10.1016/0197-4580(92)90059-7 · DOI
- Emre, 1992, The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected β-amyloid in the rat brain, Neurobiol. Aging, 13, 553, 10.1016/0197-4580(92)90055-3 · DOI
- Games, 1992, Lack of Alzheimer pathology after β-amyloid protein injections in rat brain, Neurobiol. Aging, 13, 569, 10.1016/0197-4580(92)90057-5 · DOI
- Haan, 1990, Hereditary cerebral hemorrhage with amyloidosis-Dutch type. Clinical and computed tomographic analysis of 24 cases, Arch. Neurol., 47, 649, 10.1001/archneur.1990.00530060059018 · DOI
- Kowall, 1991, An in vivo model for the neurodegenerative effects of beta-amyloid and protection by substance-P, Proc. Natl. Acad. Sci. USA, 88, 7247, 10.1073/pnas.88.16.7247 · DOI
- Kowall, 1992, In vivo neurotoxicity of β-amyloid [β(1-40)] and the β(25-35) fragment, Neurobiol. Aging, 13, 537, 10.1016/0197-4580(92)90053-Z · DOI
- Levy, 1990, Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type, Science, 248, 1124, 10.1126/science.2111584 · DOI
- Luyendijk, 1988, Hereditary cerebral haemorrhage caused by cortical amyloid angiopathy, J. Neurol. Sci., 85, 267, 10.1016/0022-510X(88)90186-4 · DOI
- Maness, 1994, Passage of human amyloid β-protein 1-40 across the murine blood–brain barrier, Life Sci., 55, 1643, 10.1016/0024-3205(94)00331-9 · DOI · Paper page
- Martel, 1996, Blood–brain barrier uptake of the 40 and 42 amino acid sequences of circulating Alzheimer's amyloid beta in guinea pigs, Neurosci. Lett., 206, 157, 10.1016/S0304-3940(96)12462-9 · DOI · Paper page
- Ohno, 1978, Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat, Am. J. Physiol., 235, H299
- Podlisny, 1993, Microinjection of synthetic amyloid β-protein in monkey cerebral cortex fails to produce acute neurotoxicity, Am. J. Pathol., 142, 17
- Poduslo, 1982, Altered blood nerve barrier in experimental lead neuropathy assessed by changes in endoneurial albumin concentration, J. Neurosci., 2, 1507, 10.1523/JNEUROSCI.02-10-01507.1982 · DOI
- Poduslo, 1988, Increase in albumin, IgG, and IgM blood–nerve barrier indices in human diabetic neuropathy, Proc. Natl. Acad. Sci. USA, 85, 4879, 10.1073/pnas.85.13.4879 · DOI
- Poduslo, 1992, Increased permeability across the blood–nerve barrier of albumin glycatedin vitroin vivo, Proc. Natl. Acad. Sci. USA, 89, 2218, 10.1073/pnas.89.6.2218 · DOI
- Poduslo, 1994, Glycation increases in permeability of proteins across the blood–nerve and blood–brain barriers, Molec. Brain Res., 23, 157, 10.1016/0169-328X(94)90222-4 · DOI
- Poduslo, 1996, Polyamine modification increases the permeability of proteins at the blood–nerve and blood–brain barriers, J. Neurochem., 66, 1599, 10.1046/j.1471-4159.1996.66041599.x · DOI
- Poduslo, 1996, Permeabilities at the blood–brain and blood–nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF, Mol. Brain Res., 36, 280, 10.1016/0169-328X(95)00250-V · DOI · Paper page
- Poduslo, 1980, Molecular weight estimation using sodium dodecyl sulfate-pore gradient electrophoresis, Anal. Biochem., 101, 394, 10.1016/0003-2697(80)90205-5 · DOI
- Rush, 1992, Intracerebral β-amyloid(25-35) produces tissue damage: Is it neurotoxic?, Neurobiol. Aging, 13, 591, 10.1016/0197-4580(92)90061-2 · DOI
- Saito, 1995, Vector-mediated delivery of1251-401-40, Proc. Natl. Acad. Sci. USA, 92, 10227, 10.1073/pnas.92.22.10227 · DOI · Paper page
- Smith, 1985, Measurement of protein using bicinchoninic acid, Anal. Biochem., 150, 76, 10.1016/0003-2697(85)90442-7 · DOI · Paper page
- Smyth, 1994, Analysis of brain injury following intrahippocampal administration of beta-amyloid in streptozotocin-treated rats, Neurobiol. Aging, 15, 153, 10.1016/0197-4580(94)90106-6 · DOI
- Snow, 1994, An important role of heparin sulfate proteoglycan (perlecan) in a model system for the deposition and persistence of fibrillar Aβ-amyloid in rat brain, Neuron, 12, 219, 10.1016/0896-6273(94)90165-1 · DOI
- Stein-Behrens, 1992, Failure of β-amyloid protein fragment 25-35 to cause hippocampal damage in the rat, Neurobiol. Aging, 13, 577, 10.1016/0197-4580(92)90058-6 · DOI
- Stephenson, 1992, In vivo effects of β-amyloid implants in rodents: Lack of potentiation of damage associated with transient global forebrain ischemia, Brain Res., 586, 235, 10.1016/0006-8993(92)91632-O · DOI
- Van Broeckhoven, 1990, Amyloid β protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch), Science, 248, 1120, 10.1126/science.1971458 · DOI
- van Duinen, 1987, Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer disease, Proc. Natl. Acad. Sci. USA, 84, 5991, 10.1073/pnas.84.16.5991 · DOI
- Waite, 1992, Solvent effects on beta protein toxicity in vivo, Neurobiol. Aging, 13, 595, 10.1016/0197-4580(92)90062-3 · DOI
- Wang, 1994, Hippocampal β-amyloid reduces locus coeruleus glutamate and tyrosine hydroxylase, Brain Res. Bull., 35, 485, 10.1016/0361-9230(94)90162-7 · DOI
- Wattendorff, 1995, Hereditary cerebral haemorrhage with amyloidosis, Dutch type (HCHWA-D): Clinicopathological studies, J. Neurol. Neurosurg. Psychiatry, 58, 699, 10.1136/jnnp.58.6.699 · DOI
- Winkler, 1994, Lack of long-term effects after β-amyloid protein injections in rat brain, Neurobiol. Aging, 15, 601, 10.1016/0197-4580(94)00054-9 · DOI
- Zlokovic, 1993, Blood–brain barrier transport of circulating Alzheimer's amyloid β, Biochem. Biophys. Res. Commun., 197, 1034, 10.1006/bbrc.1993.2582 · DOI · Paper page
- Zlokovic, 1994, Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid β, Biochem. Biophys. Res. Commun., 205, 1431, 10.1006/bbrc.1994.2825 · DOI
- Zlokovic, 1996, Glycoprotein 330/megalin: Probable role in receptor-mediated transport of apolipoprotein j alone and in a complex with Alzheimer disease amyloid beta at the blood–brain and blood–cerebrospinal fluid barriers, Proc. Natl. Acad. Sci. USA, 93, 4229, 10.1073/pnas.93.9.4229 · DOI · Paper page
Cited by
Sorted by citations
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Self-citationNeurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
Shibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., Holtzman, D. M., Miller, C. A., Strickland, D. K., Ghiso, J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10498 · Cited by 1,413
Bell, R. D., Sagare, A. P., Friedman, A. E., Bedi, G. S., Holtzman, D. M., Deane, R., & Zlokovic, B. V. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600419 · Cited by 670
Blood–Brain Barrier Dysfunction as a Cause and Consequence of Alzheimer's Disease
Erickson, M. A., & Banks, W. A. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.135 · Cited by 572
Metadata
- Authors
- Poduslo, J. F., Curran, G. L., Haggard, J. J., Biere, A. L., & Selkoe, D. J.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 1997-01
- Volume
- 4
- Issue
- 1
- Pages
- 27-34
- ISSN
- 0969-9961
- Cited by
- 52
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Permeability and Residual Plasma Volume of Human, Dutch Variant, and Rat Amyloid β-Protein 1-40 at the Blood–Brain Barrier. https://app.cochat.ai/papers/10.1006/nbdi.1997.0132
- The paper
- Poduslo, J. F., Curran, G. L., Haggard, J. J., Biere, A. L., & Selkoe, D. J. (1997). Permeability and Residual Plasma Volume of Human, Dutch Variant, and Rat Amyloid β-Protein 1-40 at the Blood–Brain Barrier. Neurobiology of Disease. https://doi.org/10.1006/nbdi.1997.0132